| D008297 |
Male |
|
Males |
|
| D008875 |
Middle Aged |
An adult aged 45 - 64 years. |
Middle Age |
|
| D010300 |
Parkinson Disease |
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) |
Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000368 |
Aged |
A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. |
Elderly |
|
| D000978 |
Antiparkinson Agents |
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. |
Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson |
|
| D001058 |
Apomorphine |
A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. |
Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm |
|
| D012646 |
Self Administration |
Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. |
Administration, Self,Administrations, Self,Self Administrations |
|
| D018491 |
Dopamine Agonists |
Drugs that bind to and activate dopamine receptors. |
Dopamine Receptor Agonists,Dopaminergic Agonists,Agonists, Dopamine Receptor,Agonists, Dopaminergic,Dopamine Agonist,Dopamine Receptor Agonist,Dopaminergic Agonist,Receptor Agonists, Dopamine,Agonist, Dopamine,Agonist, Dopamine Receptor,Agonist, Dopaminergic,Agonists, Dopamine,Receptor Agonist, Dopamine |
|
| D020018 |
Sexual Dysfunctions, Psychological |
Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994) |
Frigidity,Hypoactive Sexual Desire Disorder,Orgasmic Disorder,Psychosexual Disorders,Psychosexual Dysfunctions,Sexual Arousal Disorder,Sexual Aversion Disorder,Arousal Disorders, Sexual,Aversion Disorders, Sexual,Disorder, Psychosexual,Disorders, Orgasmic,Disorders, Psychosexual,Disorders, Sexual Arousal,Disorders, Sexual Aversion,Dysfunction, Psychological Sexual,Dysfunction, Psychosexual,Dysfunctions, Psychological Sexual,Dysfunctions, Psychosexual,Orgasmic Disorders,Psychological Sexual Dysfunction,Psychological Sexual Dysfunctions,Psychosexual Disorder,Psychosexual Dysfunction,Sexual Arousal Disorders,Sexual Aversion Disorders,Sexual Dysfunction, Psychological |
|